Logo image of ADGM

ADAGIO MEDICAL HOLDINGS INC (ADGM) Stock Fundamental Analysis

NASDAQ:ADGM - Nasdaq - US00534B1008 - Common Stock - Currency: USD

1.26  -0.03 (-2.33%)

After market: 1.24 -0.02 (-1.59%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to ADGM. ADGM was compared to 189 industry peers in the Health Care Equipment & Supplies industry. ADGM may be in some trouble as it scores bad on both profitability and health. ADGM does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year ADGM has reported negative net income.
In the past year ADGM has reported a negative cash flow from operations.
In the past 5 years ADGM reported 4 times negative net income.
In the past 5 years ADGM always reported negative operating cash flow.
ADGM Yearly Net Income VS EBIT VS OCF VS FCFADGM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 -20M -40M -60M

1.2 Ratios

ADGM's Return On Assets of -138.85% is on the low side compared to the rest of the industry. ADGM is outperformed by 88.36% of its industry peers.
ADGM has a worse Return On Equity (-337.83%) than 82.01% of its industry peers.
Industry RankSector Rank
ROA -138.85%
ROE -337.83%
ROIC N/A
ROA(3y)-230.1%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ADGM Yearly ROA, ROE, ROICADGM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -200 -400

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ADGM so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ADGM Yearly Profit, Operating, Gross MarginsADGM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 -2K -4K -6K -8K -10K

More info and screens

3

2. Health

2.1 Basic Checks

ADGM does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ADGM has more shares outstanding
ADGM has a better debt/assets ratio than last year.
ADGM Yearly Shares OutstandingADGM Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 5M 10M 15M
ADGM Yearly Total Debt VS Total AssetsADGM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

Based on the Altman-Z score of -3.00, we must say that ADGM is in the distress zone and has some risk of bankruptcy.
ADGM has a worse Altman-Z score (-3.00) than 64.55% of its industry peers.
ADGM has a Debt/Equity ratio of 0.81. This is a neutral value indicating ADGM is somewhat dependend on debt financing.
ADGM has a Debt to Equity ratio of 0.81. This is in the lower half of the industry: ADGM underperforms 72.49% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.81
Debt/FCF N/A
Altman-Z -3
ROIC/WACCN/A
WACC5.91%
ADGM Yearly LT Debt VS Equity VS FCFADGM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

A Current Ratio of 3.27 indicates that ADGM has no problem at all paying its short term obligations.
ADGM has a Current ratio (3.27) which is comparable to the rest of the industry.
A Quick Ratio of 2.93 indicates that ADGM has no problem at all paying its short term obligations.
With a decent Quick ratio value of 2.93, ADGM is doing good in the industry, outperforming 63.49% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.27
Quick Ratio 2.93
ADGM Yearly Current Assets VS Current LiabilitesADGM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for ADGM have decreased strongly by -2939.87% in the last year.
The Revenue has grown by 100.67% in the past year. This is a very strong growth!
EPS 1Y (TTM)-2939.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2222.76%
Revenue 1Y (TTM)100.67%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ADGM Yearly Revenue VS EstimatesADGM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 200K 400K 600K

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ADGM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ADGM Price Earnings VS Forward Price EarningsADGM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ADGM Per share dataADGM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 -2 -3 -4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ADGM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ADAGIO MEDICAL HOLDINGS INC

NASDAQ:ADGM (5/1/2025, 8:44:05 PM)

After market: 1.24 -0.02 (-1.59%)

1.26

-0.03 (-2.33%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners18.37%
Inst Owner Change0%
Ins Owners0.29%
Ins Owner Change0%
Market Cap19.38M
AnalystsN/A
Price TargetN/A
Short Float %1.23%
Short Ratio0.03
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 33.64
P/FCF N/A
P/OCF N/A
P/B 0.97
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-4.06
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-2.02
FCFYN/A
OCF(TTM)-1.92
OCFYN/A
SpS0.04
BVpS1.29
TBVpS-0.07
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -138.85%
ROE -337.83%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-230.1%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0.81
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 118.9%
Cap/Sales 286.11%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.27
Quick Ratio 2.93
Altman-Z -3
F-Score4
WACC5.91%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2939.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2222.76%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)100.67%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-462.64%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-19.68%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-14.84%
OCF growth 3YN/A
OCF growth 5YN/A